97715574 - BRIUMVI UBLITUXIMAB-XIIY 150 MG/6ML INJECTION FOR IV

Information

• Trademark
• 97715574

• Source

• Serial Number

  97715574

• International Classifications

  • 5 - Pharmaceutical and veterinary preparations

• Filing Date

  December 13, 2022
  2 years ago

• Transaction Date

  December 03, 2024
  15 days ago

• Status Date

  December 03, 2024
  15 days ago

• Published for Opposition Date

  July 11, 2023
  a year ago

• Location Date

  December 03, 2024
  15 days ago

• First Use Anywhere Date

  June 12, 2023
  a year ago

• First Use In Commerce Date

  June 12, 2023
  a year ago

• Status Code

  819

• Current Location

  PUBLICATION AND ISSUE SECTION

  Employee Name

  EVANKO, PATTY

• Attorney Name

  Maury M. Tepper, III

  Law Office Assigned Location Code

  N10

• Owners

  • TG THERAPEUTICS, INC

Case File Statements

• DM0000: The mark consists of the text "BRIUMVI" in black above the text "UBLITUXIMAB-XIIY 150 MG/6ML INJECTION FOR IV" in dark grey with the "B" in "BRIUMVI" partially surrounded by a light blue sphere edged in gold.
• GS0051: pharmaceutical preparations for human use, namely, pharmaceutical preparations for the prevention and treatment of central nervous system disorders, multiple sclerosis, autoimmune diseases and B-cell mediated non-oncological diseases, the foregoing featuring monoclonal antibodies
• CC0000: The color(s) black, dark grey, light blue and gold is/are claimed as a feature of the mark.
• TR0010: The wording BRIUMVI has no meaning in a foreign language.
• DS0000: "150 MG/6ML INJECTION FOR IV"

Case File Event Statements

• 12/16/2022 - 2 years ago

  1 - NEW APPLICATION ENTERED Type: NWAP

• 1/10/2023 - a year ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS

• 1/11/2023 - a year ago

  3 - NOTICE OF DESIGN SEARCH CODE E-MAILED Type: MDSC

• 3/8/2023 - a year ago

  4 - ASSIGNED TO EXAMINER Type: DOCK

• 3/9/2023 - a year ago

  5 - NON-FINAL ACTION WRITTEN Type: CNRT

• 3/9/2023 - a year ago

  6 - NON-FINAL ACTION E-MAILED Type: GNRT

• 3/9/2023 - a year ago

  7 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN

• 6/6/2023 - a year ago

  8 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 6/6/2023 - a year ago

  9 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 6/6/2023 - a year ago

  10 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 6/7/2023 - a year ago

  11 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 6/21/2023 - a year ago

  12 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP

• 7/11/2023 - a year ago

  13 - PUBLISHED FOR OPPOSITION Type: PUBO

• 7/11/2023 - a year ago

  14 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB

• 9/5/2023 - a year ago

  15 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM

• 3/4/2024 - 9 months ago

  16 - SOU TEAS EXTENSION RECEIVED Type: EEXT

• 3/4/2024 - 9 months ago

  18 - SOU EXTENSION 1 GRANTED Type: EX1G

• 3/5/2024 - 9 months ago

  19 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA

• 9/4/2024 - 3 months ago

  22 - USE AMENDMENT FILED Type: IUAF

• 3/4/2024 - 9 months ago

  17 - SOU EXTENSION 1 FILED Type: EXT1

• 11/5/2024 - a month ago

  23 - STATEMENT OF USE PROCESSING COMPLETE Type: SUPC

• 12/3/2024 - 15 days ago

  24 - ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Type: CNPR

• 12/3/2024 - 15 days ago

  25 - NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Type: SUNA

• 11/5/2024 - a month ago

  21 - CASE ASSIGNED TO INTENT TO USE PARALEGAL Type: AITU

• 9/4/2024 - 3 months ago

  20 - TEAS STATEMENT OF USE RECEIVED Type: EISU